Verge Genomics is pivoting, after the clinical trial of its ALS drug failed. Now, as Verge Labs, the company has built a brain AI model to solve patient-stratification problems for neurology clinical trials, @brittanytrang.com reports:
www.statnews.com/2026/06/16/v... via @statnews.com
As the saying goes, one man’s trash is another man’s treasure. Or as Verge Labs might put it, one company’s failed clinical trial … is that same company’s
